Vitamin B12 Injection Dosing
For adults with B12 deficiency without neurological involvement, administer hydroxocobalamin 1 mg intramuscularly three times weekly for 2 weeks, followed by lifelong maintenance of 1 mg intramuscularly every 2-3 months. 1
Initial Treatment Dosing
Without Neurological Involvement
- Loading phase: Hydroxocobalamin 1 mg IM three times weekly for 2 weeks 1
- Maintenance: 1 mg IM every 2-3 months for life 1
With Neurological Involvement
If the patient has any unexplained sensory, motor, or gait symptoms, the approach is more aggressive:
- Loading phase: Hydroxocobalamin 1 mg IM on alternate days until no further clinical improvement 1
- Maintenance: 1 mg IM every 2 months 1
- Urgent specialist referral to neurology and hematology is mandatory 1
Critical Clinical Considerations
Never give folic acid before treating B12 deficiency - this can mask the underlying B12 deficiency while allowing irreversible subacute combined degeneration of the spinal cord to progress 1, 2. This is a potentially catastrophic error that can cause permanent neurological damage.
Monitoring During Initial Treatment
- Monitor serum potassium closely in the first 48 hours and replace if necessary 2
- Check hematocrit and reticulocyte counts daily from days 5-7, then frequently until hematocrit normalizes 2
- Obtain baseline vitamin B12, folate, iron levels, hematocrit, and reticulocyte count before treatment 2
Alternative Formulations
While the guidelines prioritize intramuscular hydroxocobalamin, oral cyanocobalamin 1000 mcg daily can be considered for dietary deficiency or when malabsorption is not the cause 3, 4. However, in malabsorption states (pernicious anemia, post-bariatric surgery, gastrointestinal disease), parenteral administration is strongly preferred 5.
Practical Dosing Nuances
The evidence consistently supports 1 mg (1000 mcg) as the standard dose rather than lower doses. Studies demonstrate that significantly more B12 is retained with 1000 mcg injections compared to 100 mcg, with no disadvantage in cost or toxicity 6. The FDA label confirms that patients with pernicious anemia require monthly injections for life, and failure to maintain therapy results in return of anemia and irreversible nerve damage 2.
Individualization of Maintenance Frequency
While guidelines recommend every 2-3 months for maintenance, clinical experience suggests up to 50% of patients require more frequent dosing (ranging from every 2-4 weeks to twice weekly) to remain symptom-free 5. Titrate the injection frequency based on symptom relief, not biomarker normalization 7, 5. If symptoms recur before the next scheduled injection, shorten the interval.
Common Pitfalls to Avoid
- Do not delay treatment while investigating the cause - B12 deficiency progressing beyond 3 months can cause permanent spinal cord lesions 2
- Do not use serum B12 levels to guide maintenance dosing frequency - clinical response is the appropriate endpoint 7, 5
- Do not assume oral supplementation is adequate in malabsorption states - there is insufficient evidence that oral/sublingual can safely replace injections in these patients 5
- Do not forget lifelong maintenance - patients with pernicious anemia or malabsorption require indefinite treatment 1, 2